Topas Therapeutics
topas-therapeutics.com
Actively hiring
Neurology & CNS Therapeutics
Health Care
Biotechnology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$23.8M
2 rounds on record
Latest round
$23.8M
Venture round · Oct 2020 · 5 yr ago
Team
51-200
employees, estimated range
Grants
$441k
1 grant · CORDIS
Backers
1
Epidarex Capital
The money's age
Long since its last round
71 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 6, 2024
New executive Topas Therapeutics Appoints Hugo Fry as CEO · businesswire.com
Mar 1, 2021
Won a grant $441k · CORDIS
Oct 19, 2020
Raised a round Venture round $23.8M · led by Vesalius BioCapital III · YahooFinance
1993
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Mar 2021 | $441k | — | CORDIS |
| Venture round | Oct 2020 | $23.8M | Vesalius BioCapital III lead, BioMedPartners lead | YahooFinance |
Registers and programsofficial lists and records that name the company
| Legal entity | Topas Therapeutics GmbH | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Epidarex Capital Similar startupsby what they do, their industry and backers
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is…
Biossil is an AI native biopharma company based in Toronto. It is advancing late-stage programs in life-threatening indications with urgent…
SFA Therapeutics is developing a next-generation oral immune tolerance therapy for psoriasis. Our investigational approach is designed to…
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
Advanced Treg Therapy for Autoimmune Diseases. For more information, contact [email protected].
News
Topas Therapeutics with two presentations at the Sixth Newcastle Therapeutic Tolerance Workshop
The Newcastle Therapeutic Tolerance Workshop brings together leading researchers and industry experts to discuss the latest advances in immune tolerance. Topas Therapeutics is contributing to the scientific program with two presentations: Sabine Fleischer
Read more
Report
Topas presents nanoparticle platform at Nanotech in Life Science conference
Topas Therapeutics will present at the Nanotech in Life Science conference hosted by Fraunhofer IMTE in Lübeck on 14 April 2026. The keynote will highlight Topas' nanoparticle platform designed to target liver sinusoidal endothelial cells (LSECs) for the
Read more
Report
Topas to present at the 9th Antigen-Specific Immune Tolerance Summit
Topas Therapeutics will present at the 9th Antigen-Specific Immune Tolerance Summit in Boston on 4 March 2026. The presentation will highlight Topas' approach to assessing antigen-specific immune tolerance induction and advancing precision immunotherapies
Read more
Report
Topas presents new TPM502 Phase 2a data at UEG Week
Topas Therapeutics presents new data from its Phase 2a clinical study of TPM502 at UEG Week in Berlin. The results provide further evidence that TPM502 induces antigen-specific immune tolerance through targeted modulation of gluten-specific T cells in pat
Read more
Report
Topas to present at BioCentury's GrandRounds Europe
Topas Therapeutics will present its antigen-specific immune tolerance platform at BioCentury's Grand Rounds Europe in Cambridge on 18 September 2026. The presentation will highlight Topas' antigen-specific immune tolerance platform for autoimmune and anti
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hamburg
Germany
Registered seat
50-200 est. staff